Sarar technology for the application of copper-64 in biology and materials science

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 52, Issue 2, 2008, Pages 193-202

  Smith, S V ^a,b  

^a Centre of Excellence in Antimatter Matter Studies (ARC CAMS)   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Cooper; Molecular imaging; Technology

Indexed keywords

DIAMSAR COBALT COMPLEX; DIAMSAR COPPER COMPLEX; DIAMSAR CU 64; DINOSAR COBALT COMPLEX; MICROSPHERE CO 57; MICROSPHERE CU 64; MONOCLONAL ANTIBODY 14.G2A SARAR CU 64; MONOCLONAL ANTIBODY B.72.3 PENTETATE IN 111; MONOCLONAL ANTIBODY B.72.3 SARAR CU 64; MONOCLONAL ANTIBODY CH14.18 SARAR CU 64; NITROGEN; PENICILLAMINE; RADIOACTIVE MICROSPHERE; RADIOPHARMACEUTICAL AGENT; SARAR CO 57; SARAR CU 64; SARAR NI 57; SARCOPHAGINE COBALT COMPLEX; SARCOPHAGINE COPPER COMPLEX; SULFUR; TRACER;

COLORECTAL CANCER; COMPLEX FORMATION; CONFERENCE PAPER; DRUG CLEARANCE; DRUG DESIGN; DRUG PURITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; INTOXICATION; MELANOMA; METAL BINDING; MOLECULAR IMAGING; MOLECULAR INTERACTION; MOLECULAR STABILITY; NANOTECHNOLOGY; NEUROBLASTOMA; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PHYSICAL CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; ROOM TEMPERATURE; THERMODYNAMICS; WILSON DISEASE;

ANILINE COMPOUNDS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BIOLOGICAL AVAILABILITY; BIOLOGY; BIOTECHNOLOGY; COPPER; IMMUNOCONJUGATES; ISOTOPE LABELING; MATERIALS TESTING; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 44249127739     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Lehn JM. Cryptates: the chemistry of macropolycyclic inclusion complexes. Acc Chem Res 1978;11:49-57.
2. Creaser II, Harrowfield JM, Herlt AJ, Sargeson AM, Springborg J, Geue RJ et al. Sepulchrate: a macrobicyclic nitrogen cage for metal ions. J Am Chem Soc 1977;99:3181-92.
3. Sargeson AM. Encapsulated metal ions. Pure Appl Chem 1984;56:1603-19.
4. Sargeson AM. Developments in the synthesis and reactivity of encapsulated metal ions. Pure Appl Chem 1986;58:1511-22.
5. Sargeson AM. Cages for metal ions. Chem Aust 1991;58:176-8.
6. Harrowfield JM, Lawrance GA, Sargeson AM. Facile synthesis of a macrobicyclic hexaammine cobalt(III) complex based on tris(ethylenediamine) cobalt(III). An advanced undergraduate inorganic laboratory experiment. J Chem Educ 1985;62:804-6.
7. Angus PM, Geue RJ, Jensen NKB, Larsen, FK, Chang JQ, Sargeson AM. An unusual pendant-arm macrocycle formed by condensation of a cobalt(III) tripodal complex with methanal. J Chem Soc 2002;22:4260-3.
8. Hohn A, Geue RJ, Sargeson AM. A new strategy for the metal template synthesis of organic metal ion cages. J Chem Soc Chem Commun 1990;21:1473-5.
9. Geue RJ, Hohn A, Ralph SF, Sargeson AM, Willis AC. A new template encapsulation strategy for larger cavity metal ion cages. J Chem Soc Chem Commun 1994;12:1513-5.
10. Ralph SF, Sheil MM, Hick LA, Geue RJ, Sargeson AM. An electrospray mass spectrometry study of some metal-ion cage complexes. J Chem Soc Chem Commun Inorg Chem 1996;23:4417-24.
11. Bernhardt PV, Bramley R, Geue RJ, Ralph SF, Sargeson AM. An expanded cavity hexaamine cage for copper(II). Dalton Trans 2007;12:1244-9.
12. Osvath P, Sargeson AM, McAuley A, Mendelez RE, Subramanian S, Zaworotko MJ et al. cobalt cage complexes with N3S3 donor sets and differing cavity sizes: a novel macrobicyclic cage with a contracted cap. Inorg Chem 1999;38:3634-43.
13. Bernhardt PV, Bramley R, Engelhardt LM, Harrowfield JM, Hockless DCR, Korybut-Daszkiewicz BR et al. Copper(II) complexes of substituted macrobicyclic hexaamines: combined trigonal and tetragonal distortions. Inorg Chem 1995;34:3589-99.
14. Geue RJ, Osvath P, Sargeson AM, Acharya KR, Noor SB, Row TNG. The reaction of a nitro-capped cobalt(III) cage complex with base: the crystal structure of a contracted cage complex, and the mechanism of its formation. Aust J Chem 1994;47:511-27.
15. Creaser II, Engelhardt LM, Harrowfield JM, Sargeson AM, Skelton BW, White AH. Syntheses and structures of manganese(II) and manganese(III) nitrate diaminosarcophagine complexes. Aust J Chem 1993;46:465-76.
16. Creaser II, Harrowfield JM, Lawrance GA, Mulac W, Sangster D, Sargeson AM et al. Rapid reduction of [CuII(sarcophagine)]2+ ion and elimination of copper(I) from the cage: a pulse radiolysis study. J Coord Chem 1991;23:389-95.
17. Martell AM, Smith RM. Critical stability constants, vol. 62nd Suppl. New York: Plenum Press; 1989.
18. Grondahl L, Hammershoi A; Sargeson AM, Thoem VJ. Stability and kinetics of acid- and anion-assisted dissociation reactions of hexaamine macrobicyclic mercury(ii) complexes. Inorg Chem 1997;36:5396-5403.
19. Studer M, Kaden TA. Metal complexes with macrocyclic ligands. Part XXV. One-step synthesis of mono-N-substituted azamacrocycles with a carboxylic group in the side-chain and their complexes with Cu2+ and Ni2+. Helv Chim Acta 1986;69:2081.
20. Motekaitis RJ, Reichert DE, Martell AE, Welch MJ. Stability and structure of activated macrocycles ligands with biological applications. Inorg Chem 1996;35:3821-7.
21. Sargeson AM. The potential for the cage complexes in biology. Coord Chem Rev 1996;151:89-114.
22. Walker GW, Geue RJ, Sargeson AM, Behm CA. Surface-active cobalt cage complexes: synthesis, surface chemistry, biological activity, and redox properties. Dalton Trans 2003;15:2992-3001.
23. Bingham MJ, Sargeson AM, McArdle HJ. Characterization of intracellular copper pools in rat hepatocytes using the chelator diamsar. Am J Physiol 1997;272:G1400-7.
24. Smith SV. Using molecular imaging with copper-64 in the drug discovery process. Expert Opin Drug Discov. In press 2007.
25. Smith SV. Molecular imaging with copper-64. J Inorg Biochem 2004;98:1874-901.
26. Anderson CJ, Connett JM, Schwarz SW, Rocque PA, Guo LW, Philpott GW et al. Copper-64-labeled antibodies for PET imaging. J Nucl Med 1992;33:1685-91.
27. Connett JM, Buettner TL, Anderson CJ. Maximum tolerated dose and large tumour radioimmunotherapy studies of 64Cu-labeled Mab 1A3 in a colon cancer model. Clin Cancer Res 1999;5:3207s-12s.
28. Wu AM, Yazaki PJ, Tsai S, Nguyen K, Anderson AL, McCarthy DW et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A 2000;97:8495-500.
29. Bennett KL, Smith SV, Lambrecht RM, Truscott RJW, Shiel MM. Rapid characterization of chemically-modified proteins by electrospray mass spectrometry. Bioconjug Chem 1996;7:16-22.
30. Smith SV, Harrowfield J, Di Bartolo NM Sargeson AM. Cryptate compounds and methods for diagnosis and therapy, PCT Int. Appl. 2000; WO 0040585. Europe 1147111. Granted USA patent 6869589 22 Mar 2005. Aust 780635 21 Jul 2005.
31. Di Bartolo NM, Sargeson AM, Donlevy TM, Smith SV. Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging. J Chem Soc 2001;15:2303-9.
32. Smith SV, Lambrecht RM, Schmidt P, Lee F. Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents. U.S. (1998), 51 pp., USA 5,550,160 (1996). Aust 671465(1992); Eur 0590766 A3 (2000) Japan 285888 (1995).
33. Smith SV, Huang S, Helm P. A comparison of 64Cu2+ Complexation by polyaza and polyazacarboxylate macrocyclic and biscyclic ligands International Symposium on Radiopharmaceutical Sciences, Aachen, 2007.
34. Sarka L, Buria L, Brucher E. The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging chem. Eur J 2000;6:719-24.
35. Margerum DW, Byadalck TJ. Multidentate ligand kinetics. II. Zinc(II) and ethylenediaminetetraacetatonickelate(II) with copper(II) catalysis. Inorg Chem 1962;1:852-6.
36. Di Bartolo NM, Sargeson AM, Smith SV. New 64Cu imaging agents for personalised medicine and drug development using the Hexa-Aza Cage, SarAr. Org Biomol Chem 2006;4:3350-7.
37. Brown BA, Comeau RD, Jones P, Liberatore FA, Neacy WP, Sands H et al. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either iodine-125 or indium-111. Can Res 1987; 47:1149-54.
38. Di Bartolo N. Ph.D. Thesis Australian National University, Australia, 2002.
39. Hennig IM, Laissue JA, Horisberger U, Reubi JC. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 1995;61:786-92.
40. Voss SD, Smith SV, DiBartolo N, McIntosh L, Cyr E, Bonab A et al. 64Cu-SarAr-antibody conjugates for PET imaging of neuroblastoma. Society of Nuclear Medicine Annual Meeting, San Diego, 5 June 2006.
41. Voss SD, Smith SV, DiBartolo N, McIntosh LJ, Cyr EM, Bonab AA et al. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. PNAS 2007;104:17489-93.